Biostatistics Core
Biostatistics Core
批准号:
8589114
负责人:
MARK KESTER
金额:
$2.3万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-10 至 2018-08-31
关键词:
Advisory CommitteesAnimalsAreaBioinformaticsBiological MarkersBiological SciencesBiometryBiostatistics CoreClinicalClinical SciencesCommunicationCommunitiesComputer HardwareComputer softwareConfidentialityDNADataData AnalysesData CollectionDatabasesDoseEnsureExperimental DesignsFloorHealth SciencesHuman ResourcesInstitutesInstitutionKnowledgeLearningLocationMalignant NeoplasmsManuscriptsMetabolismMethodologyPreparationProteomicsPublic HealthPublicationsResearchResearch PersonnelResourcesSample SizeSecureSecurityServicesSphingolipidsWorkcost effectivenessdata integritydata managementdata sharingdesignexperienceimprovedmeetingsmemberprogramsresearch studystatistical servicesymposiumtool
中文摘要
The Biostatistics Core serves as the focal point of biostatistics support for all the four Projects. The Core will provide regular advice on experimental design such as selection of end points, sample size and power, and optimal allocation of animal and dose. The Core handles data management of the four Projects in a secure central location and in a format consistent across Projects. The Core will perform expert statistical analyses that optimally answer the research question and represent state of the art practice. The Core will also facilitate data sharing with the general scientific community.
The Core is staffed by two experienced biostatisticians who have daily working relationships with the Project investigators. Their offices are on the third floor of the Cancer Institute building, in close proximity to most of the Program Project investigators. The Core biostatisticians have been an integral part of the P01 application through working on experimental design, analyzing preliminary data and developing a detailed and tailored statistical plan for each Project. The Core biostatisticians have made a concerted effort to learn the clinical and biological science in this AML Program Project so as to provide the strongest statistical service. The Core has access to all needed software such as Microsoft Office 2007, SAS 9.3 and R. A dedicated Biostatistics Core provides easy and guaranteed access for the Program Project investigators and also allows biostatisticians to specialize in the Project areas, in terms of the scientific knowledge and in biostatistics expertise
A dedicated Core provides timely and high quality biostatistics service as its focus. Cost-effectiveness is enhanced because the cumulative experience of all Core personnel and the combined facilities and resources are available to each of the four Projects. The Biostatistics Core also serves as an interface to the larger resources in biostatistics, data management and computing in the Department of Public Health Sciences. No additional computer hardware and software are needed.
英文摘要
The Biostatistics Core serves as the focal point of biostatistics support for all the four Projects. The Core will provide regular advice on experimental design such as selection of end points, sample size and power, and optimal allocation of animal and dose. The Core handles data management of the four Projects in a secure central location and in a format consistent across Projects. The Core will perform expert statistical analyses that optimally answer the research question and represent state of the art practice. The Core will also facilitate data sharing with the general scientific community.
The Core is staffed by two experienced biostatisticians who have daily working relationships with the Project investigators. Their offices are on the third floor of the Cancer Institute building, in close proximity to most of the Program Project investigators. The Core biostatisticians have been an integral part of the P01 application through working on experimental design, analyzing preliminary data and developing a detailed and tailored statistical plan for each Project. The Core biostatisticians have made a concerted effort to learn the clinical and biological science in this AML Program Project so as to provide the strongest statistical service. The Core has access to all needed software such as Microsoft Office 2007, SAS 9.3 and R. A dedicated Biostatistics Core provides easy and guaranteed access for the Program Project investigators and also allows biostatisticians to specialize in the Project areas, in terms of the scientific knowledge and in biostatistics expertise
A dedicated Core provides timely and high quality biostatistics service as its focus. Cost-effectiveness is enhanced because the cumulative experience of all Core personnel and the combined facilities and resources are available to each of the four Projects. The Biostatistics Core also serves as an interface to the larger resources in biostatistics, data management and computing in the Department of Public Health Sciences. No additional computer hardware and software are needed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ceramide Nanoliposomes in Combination with Focused Ultrasound for Treating Breast Cancer
-
批准号:9750255
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2018
-
负责人:MARK KESTER
-
依托单位:
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
-
批准号:10206045
-
项目类别:
-
资助金额:$55.31万
-
财政年份:2017
-
负责人:MARK KESTER
-
依托单位:
Combination of ceramide and immunotherapy in treatment of hepatocellular cancer
-
批准号:9403358
-
项目类别:
-
资助金额:$53.12万
-
财政年份:2017
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:9020214
-
项目类别:
-
资助金额:$31.32万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Clinical Trial of Ceramide nanoLiposomes in AML
-
批准号:10160825
-
项目类别:
-
资助金额:$57.19万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Administrative Core
-
批准号:8589115
-
项目类别:
-
资助金额:$8.56万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:8827284
-
项目类别:
-
资助金额:$31.32万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:8638905
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeting Ceramide Metabolism in AML
-
批准号:8554594
-
项目类别:
-
资助金额:$30.57万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeted Sphingolipid Metabolism for Treatment of AML
-
批准号:10160824
-
项目类别:
-
资助金额:$199.55万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:8435991
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeted Sphingolipid Metabolism for Treatment of AML
-
批准号:8552151
-
项目类别:
-
资助金额:$198.9万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeting Acid Ceramidase in AML
-
批准号:8554595
-
项目类别:
-
资助金额:$32.75万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeted Sphingolipid Metabolism for Treatment of AML
-
批准号:8732613
-
项目类别:
-
资助金额:$192.93万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Novel Nanoparticle Therapy for Pancreatic Cancer
-
批准号:9248264
-
项目类别:
-
资助金额:$31.31万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
Targeting Sphingosine Kinase in AML
-
批准号:8554596
-
项目类别:
-
资助金额:$22.07万
-
财政年份:2013
-
负责人:MARK KESTER
-
依托单位:
The Role of Glycosphingolipids in Diabetic Retinopathy
-
批准号:7903885
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2009
-
负责人:MARK KESTER
-
依托单位:
The Role of Glycosphingolipids in Diabetic Retinopathy
-
批准号:8106211
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2009
-
负责人:MARK KESTER
-
依托单位:
The Role of Glycosphingolipids in Diabetic Retinopathy
-
批准号:7732069
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2009
-
负责人:MARK KESTER
-
依托单位:
PKC zeta as a Target for Ceramide
-
批准号:7148916
-
项目类别:
-
资助金额:$36.51万
-
财政年份:2006
-
负责人:MARK KESTER
-
依托单位:
海外基金